Description
MDN19780 is a Functionalized von-Hippel-Lindau protein (VHL) ligand for PROTAC research and development. It incorporates an E3 ligase ligand plus an alkylC9 linker with terminal carboxylic acid ready for conjugation to a target protein ligand. MDN19780 is Part of a range of functionalized tool molecules for PROTAC R&D. This product has no formal name.
Uses
(S,R,S)-AHPC-CO-C9-acid is an E3 ligase ligand-linker conjugate that can be connected to the ligand for protein to form PROTACs.
References
[1] Xu J, et al. AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway-Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B. Cancer Discov. 2021 Jul 23. DOI:
10.1158/2159-8290.CD-20-0815